| (210) | Number of the EPO application | 19852050 |
| (220) | Filing date of the EPO application | 2019.08.23 |
| (80) | EPO patent specification publication (B) | EPB nr. 08/2026, 2026.02.18 |
| (110) | EPO patent number | 3840755 |
| (21) | Number of the application | e 2021 0599 |
| (71) | Name(s) of applicant(s), code of the country | Terns, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | KIRSCHBERG Thorsten A., US;
HALCOMB Randall, US;
XU Yingzi, US;
ROMERO F. Anthony, US; |
| (73) | Name(s) of owner(s), code of the country | Terns, Inc., US; |
| (54) | Title of the invention | THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/501 (2006.01.01); A61P 3/00 (2006.01.01); C07D 413/12 (2006.01.01) |
| (52) | Cooperative Patent Classification | C07D 413/12 (EP); A61P 3/00 (EP) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.08.31 |
| (30) | Priority | 201862722312 P, 2018.08.24, US; 201962867117 P, 2019.06.26, US |
| (86) | International application | PCT/US2019/047968, 2019.08.23 |
| (87) | International publication | WO 2020/041741, 2020.02.27 |